COVID-19 is a novel coronavirus responsible for a world-wide pandemic. When people get sick with the virus that causes COVID-19, they may experience symptoms of high fever, cough, shortness of breath and flu-like symptoms. Multiple vaccines have been developed against this virus.
In order to participate, you must:
As part of the study, we will mix and match different vaccines as a booster dose and study the safety and the immune response. We ask that you agree to donate blood to study your immune response to the vaccines.
The Institute of Human Virology (IHV) and the Center for Vaccine Development and Global Health (CVD), organized research centers of the University of Maryland School of Medicine, are conducting an experimental COVID-19 booster study in collaboration with the National Institutes of Health. There are no direct benefits to participation, but the results may help us understand the immune response to COVID-19 vaccines.
This study will require approximately 7 clinic visits over a 12-month time span, to follow the safety and the immune response to the vaccine and/or boosters. If you have not received a COVID-19 injection and are willing to do so, a second portion of the study will require 14-15 visits over 12-24 months. Eligible participants will be compensated for completing all the study visits and procedures.
If you are interested in participating in the study and would like more information about what it takes to qualify, please click the link below or call the Institute of Human Virology at 410-706-7926.
Kirsten E. Lyke, MD